Journal
STEROIDS
Volume 77, Issue 6, Pages 644-654Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.steroids.2012.02.009
Keywords
Carbon isotope ratios (CIR); Human chorionic gonadotropin (HCG); Doping control; Administration study; Endogenous steroids
Funding
- FIFA Medical Assessment and Research Centre (F-MARC)
Ask authors/readers for more resources
Several factors influencing the carbon isotope ratios (CIR) of endogenous urinary steroids have been identified in recent years. One of these should be the metabolism of steroids inside the body involving numerous different enzymes. A detailed look at this metabolism taking into account differences found between steroids excreted as glucuronides or as sulphates and hydrogen isotope ratios of different steroids pointed out possibility of unequal CIR at the main production sites inside the male body - the testes and the adrenal glands. By administration of beta-HCG it is possible to strongly stimulate the steroid production within the testes without influencing the production at the adrenal glands. Therefore, this treatment should result in changed CIR of urinary androgens in contrast to the undisturbed pre-treatment values. Four male volunteers received three injections of beta-HCG over a time course of 5 days and collected their urine samples at defined intervals after the last administration. Those samples showing the largest response in contrast to the pre-administration urines were identified by steroid profile measurements and subsequent analysed by GC/C/IRMS. CIR of androsterone. etiocholanolone, testosterone, 5 alpha- and 5 beta-androstanediol and pregnanediol were compared. While pregnanediol was not influenced, most of the investigated androgens showed depleted values after treatment. The majority of differences were found to be statistically significant and nearly all showed the expected trend towards more depleted delta C-13-values. These results support the hypothesis of different OR at different production sites inside the human body. The impact of these findings on doping control analysis will be discussed. (c) 2012 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available